These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34922827)

  • 1. Detection of second primary lung cancers on surveillance imaging following stereotactic ablative radiotherapy for non-small cell lung cancer.
    Aldin MK; Qi L; Zhou X; Kahn LA; Daly ME
    Clin Lung Cancer; 2022 May; 23(3):e222-e230. PubMed ID: 34922827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
    Spratt DE; Wu AJ; Adeseye V; Din SU; Shaikh F; Woo KM; Zhang Z; Foster A; Rosenzweig KE; Gewanter R; Huang J; Rimner A
    Clin Lung Cancer; 2016 May; 17(3):177-183.e2. PubMed ID: 26602271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis.
    Zheng X; Sun Y; Ye K; Fan C; Wang X; Yang Y; Jiao R; Ge H
    Thorac Cancer; 2021 Mar; 12(6):899-905. PubMed ID: 33529496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Disease Recurrence after SABR for Early Stage Non-Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy.
    Verstegen NE; Lagerwaard FJ; Hashemi SM; Dahele M; Slotman BJ; Senan S
    J Thorac Oncol; 2015 Aug; 10(8):1195-200. PubMed ID: 26200274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
    Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
    Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer.
    Steber CR; Hughes RT; Soike MH; Helis CA; Nieto K; Jacobson T; Nagatsuka M; McGinnis HS; Leyrer CM; Farris MK
    Acta Oncol; 2021 May; 60(5):605-612. PubMed ID: 33645424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second primary lung cancers following a diagnosis of primary head and neck cancer.
    Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC.
    Leroy T; Monnet E; Guerzider S; Jacoulet P; De Bari B; Falcoz PE; Gainet-Brun M; Lahourcade J; Alfreijat F; Almotlak H; Adotevi O; Pernet D; Polio JC; Desmarets M; Woronoff AS; Westeel V
    Lung Cancer; 2019 Nov; 137():23-30. PubMed ID: 31521979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.
    Rice D; Kim HW; Sabichi A; Lippman S; Lee JJ; Williams B; Vaporciyan A; Smythe WR; Swisher S; Walsh G; Putnam JB; Hong WK; Roth J
    Ann Thorac Surg; 2003 Oct; 76(4):1001-7; discussion 1007-8. PubMed ID: 14529975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
    Tonneau M; Richard C; Routy B; Campeau MP; Vu T; Filion E; Roberge D; Mathieu D; Doucet R; Beliveau-Nadeau D; Bahig H
    Radiother Oncol; 2023 Aug; 185():109697. PubMed ID: 37169303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.
    Senthi S; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
    Lancet Oncol; 2012 Aug; 13(8):802-9. PubMed ID: 22727222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
    Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
    JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
    Wink KCJ; Löck S; Rossi M; van Baardwijk A; Belderbos J; de Ruysscher D; Troost EGC
    Radiother Oncol; 2019 Feb; 131():120-126. PubMed ID: 30773178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis.
    Chiang A; Thibault I; Warner A; Rodrigues G; Palma D; Soliman H; Jain S; Poon I; Cheung P
    Radiother Oncol; 2016 Mar; 118(3):478-84. PubMed ID: 26795773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
    Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
    J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Elbanna M; Shiue K; Edwards D; Cerra-Franco A; Agrawal N; Hinton J; Mereniuk T; Huang C; Ryan JL; Smith J; Aaron VD; Burney H; Zang Y; Holmes J; Langer M; Zellars R; Lautenschlaeger T
    Clin Lung Cancer; 2021 May; 22(3):e342-e359. PubMed ID: 32736936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
    Soldà F; Lodge M; Ashley S; Whitington A; Goldstraw P; Brada M
    Radiother Oncol; 2013 Oct; 109(1):1-7. PubMed ID: 24128806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy was associated with the lower incidence of metachronous second primary lung cancer.
    Hu ZG; Tian YF; Li WX; Zeng FJ
    Sci Rep; 2019 Dec; 9(1):19283. PubMed ID: 31848368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Jacobs CD; Mehta K; Gao J; Wang X; Salama JK; Kelsey CR; Torok JA
    Clin Lung Cancer; 2022 Mar; 23(2):177-184. PubMed ID: 34301453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.